Logo

Personalis: Kenneth Widder, Alan Colowick

Jun 16, 2023

Personalis has appointed Kenneth Widder to its board of directors. Widder currently serves on the boards of QuidelOrtho and Evoke Pharma. He has over 40 years of experience working with biomedical companies, including Sydnexis, OrphoMed, Sytera, NovaCardia, Santarus, and Molecular Biosystems. He was also a general partner at LVP Life Science Ventures and Windamere Venture Partners. He holds an MD from Northwestern University and was trained in pathology at Duke University.

The company also announced that Alan Colowick has resigned his position as a director of the company, effective June 12.

Breaking News
The Scan

Cystatin C Plays Role in Immunosuppression, Cancer Immunotherapy Failure, Study Finds

A study in Cell Genomics provides insight into how glucocorticoids can lead to cancer immunotherapy failure via cystatin C production.

Aging, Species Lifespan Gene Expression Signatures Overlap

An Osaka Metropolitan University team reports in Nucleic Acids Research that transcriptional signatures of aging and maximum lifespan have similarities.

Splicing Subgroup Provides Protocols for Evaluating Splicing Variant Data

The group presents their approach on how to apply evidence codes to splicing predictions and other data in the American Journal of Human Genetics.

Single-Cell Transcriptomic Atlas of Mouse Cochlea to Aid Treatment Development

Researchers in PNAS conducted single-cell and single-nuclear sequencing of about 120,000 cells at three key timepoints in cochlear development to generate a transcriptomic atlas.